Browsing Pathways
Showing 49661 -
49670 of 605359 pathways
SMPDB ID | Pathway Name and Description | Pathway Class | Chemical Compounds | Proteins |
---|---|---|---|---|
SMP0145106View Pathway |
Propylparaben Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0145111View Pathway |
Geraniol Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0145113View Pathway |
Aripiprazole lauroxil Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0145118View Pathway |
p-tert-Butylphenol-formaldehyde resin (low molecular weight) Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0145099View Pathway |
Synthetic camphor Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0145413View Pathway |
Cyproheptadine H1 Antihistamine Neurological Sleep Action PathwayCyproheptadine is an ethanolamine class H1 antihistamine used to treat insomnia and allergy symptoms such as hay fever and hives. It is also used with pyridoxine in the treatment of nausea and vomiting in pregnancy. H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria.
Wakefulness is regulated by histamine in the tuberomammillary nucleus, a part of the hypothalamus. Histidine is decarboxylated into histamine in the neuron. Histamine is transported into synaptic vesicles by a monoamine transporter then released into the synapse. Normally histamine would activate the H1 histamine receptor on the post-synaptic neuron in the tuberomammillary nucleus. Cyproheptadine inhibits the H1 histamine receptor, preventing the depolarization of the post-synaptic neuron. This prevents the wakefulness signal from being sent to the major areas of the brain, causing sleepiness.
|
Drug Action
|
||
SMP0145418View Pathway |
Cyclizine H1 Antihistamine Neurological Sleep Action PathwayCyclizine is an ethanolamine class H1 antihistamine used to treat insomnia and allergy symptoms such as hay fever and hives. It is also used with pyridoxine in the treatment of nausea and vomiting in pregnancy. H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria.
Wakefulness is regulated by histamine in the tuberomammillary nucleus, a part of the hypothalamus. Histidine is decarboxylated into histamine in the neuron. Histamine is transported into synaptic vesicles by a monoamine transporter then released into the synapse. Normally histamine would activate the H1 histamine receptor on the post-synaptic neuron in the tuberomammillary nucleus. Cyclizine inhibits the H1 histamine receptor, preventing the depolarization of the post-synaptic neuron. This prevents the wakefulness signal from being sent to the major areas of the brain, causing sleepiness.
|
Drug Action
|
||
SMP0145383View Pathway |
Fluoride ion Drug Metabolism Pathway |
|
|
|
SMP0145394View Pathway |
Nomifensine Drug Metabolism Pathway |
|
|
|
SMP0145388View Pathway |
Clobetasol Drug Metabolism Pathway |
|
|
Showing 49661 -
49670 of 65006 pathways